From the Editor's Desk
August 2014 Global Forum Now Online: Cloud computing is a model for enabling convenient, on-demand network access to a shared pool of configurable computing resources (networks, servers, storage, applications and services) that can be rapidly provisioned and released with minimal management or service provider interaction. This issue’s Special Section: Cloud Computing explores its promise of increased IT availability, agility, and cost savings, and the challenges it presents to traditional data center and enterprise application design and management.
Also Featured: Session and event reports from our DIA 2014 50th Annual Meeting: Celebrate the Past – Invent the Future; reports from our 1st Project Management Training Course for Clinical Study Sites and 3rd CMC Forum in Japan; previews of our 8th Annual European Medical Information and Communications Conference and 11th Latin American Congress of Clinical Research: LACCR 2014, and more.
Read the August issue.
FDA Advertising & Promotion Coverage from DIA's 25th Annual Workshop: Marketing Pharmaceuticals 2014
Read FDA Advertising & Promotion's Report
Digital Health Coalition (DHC) Coverage from DIA's 25th Annual Workshop: Marketing Pharmaceuticals 2014 - Regulating Drug Marketing in the Ever-Changing Regulatory/Legal/Healthcare Environment
Read DHC's Report
Drug Shortages Reduced in US While Disruptions Remain
CDC: Drug-resistant infections are urgent health threat in U.S.
Editor In Chief Commentary: Therapeutic Innovation & Regulatory Science - September 2014 Steven P Spielberg MD, PhD Discusses The role of the journal in helping to develop and validate best practices for Clinical Trial Management.
Read full commentary.
Read more TIRS articles.
NEW! Read our blog.
DIA Launches New TIRS Blog
DIA’s journal, Therapeutic Innovation & Regulatory Science, has launched a new blog, titled “Collaborate to Innovate.” The blog aims to further public conversation about global therapeutic advances and regulatory policies by offering expert insight on current trends and fresh perspectives on timely industry news. Read the blog. Don’t forget to follow the blog to stay current on new entries.
The blog is just another facet of TIRS’ multimedia approach to industry news. We also offer monthly podcasts, featuring commentary by industry experts. They are available on the blog. Listen to Podcasts.
Both the blog and our podcasts are complimentary to all site visitors, so please share them with your professional network.
New! DIA Europe and Director Jytte Lyngvig were spotlighted in SCRIP100.com.
Read their profile "A Forum for Future Leaders."
What Lies Ahead for 2014?
DIA's second annual What Lies Ahead? report, provides expert insight into the year ahead for pharmaceuticals, biotechnology, and the product development of medical devices.
New! Content Currents
DIA's Content Currents provides important new global regulatory developments and their impact on pharmaceutical, biotechnology, and medical product development.
Read current issue.
Today's Top Story
In his article, EURO EXCHANGE, author Graham Hughes discusses this year’s 25th annual DIA Euromeeting in Amsterdam and reflects on his 15 years of attending DIA events.
Recent Press Releases
Meetings & Training
DIA’s comprehensive educational portfolio reflects and advances innovation in the pharmaceutical, biotechnology, medical device, and related fields and facilitates open dialogue among key professionals from industry, government, academia, and patient organizations. Professional development options include:
Conferences & Meetings | In-Person Training | In-company Training |Online Learning | Certificate Programs
Upcoming educational opportunities in your region:
2014 DIA China Calendar of Events
New! Free access to one of DIA's archived webinars featuring up-to-the-minute information about the latest developments in the medical product industry
Just added! The Impact of Drug Shortages on the Pharmaceutical Industry
More than 18,000 members worldwide look to DIA as the only global, neutral, nonprofit, multidisciplinary association to address the challenges you face every day. Take advantage of all the benefits of membership, including:
View China Membership Brochure
DIA ConneX is a trusted, interactive, web-based network that links DIA’s 18,000-member global community. DIA members use ConneX to collaborate, communicate, network, and exchange information. Through ConneX, DIA members:
- Share documents
- Engage in online discussions
- Post community event information
- Make announcements and post news
- Join Communities (formerly SIACs)
Directions on how to access and manage your DIA Membership
Exhibiting & Advertising
Showcase your company's products or services to key decision-makers from across the pharmaceutical, biotechnology, medical device, and related fields.
Contract Service Organization (CSO) Directory
Reserve your spot in our exclusive print and online partner directory featuring full-page descriptions and contact information for yours and other clinical trial and medical product development service companies around the world.
View partner listings.
Join DIA and an anticipated 450+ companies with a booth at the DIA 2014 50th Annual Meeting!
Upcoming exhibiting opportunities in your region:
Advertise your company's products and services to professionals from the pharmaceutical, biotechnology, medical device, and related sectors.
Place your advertising message in front of more than 18,000 professionals involved in every aspect of medical product discovery, development, and delivery.
New Era for Communities
DIA is a global member association that provides knowledge resources across the full spectrum of medical product development. In the last few years the organization has expanded that global reach and will continue to grow to meet the need for health care knowledge exchange around the world.
As DIA’s reach expands globally we believe a name change is necessary. Our global volunteers came to consensus on "Community" to replace "SIACs." This change will enhance the visibility of the groups and make it much easier to recognize their purpose.
Each Community is led by a chairperson who is responsible for the overall activities of the Community. View complete list of Community chairpersons.
DIA offers students many opportunities to get involved and contribute in a collegial, inclusive, collaborative, positive, respectful, and professional environment in support of DIA’s mission. available student opportunities include:
- Student Volunteer Program
- Young Professionals Fellowship Program
- Student Fellowship Program
- Complimentary EuroMeeting registration
- Student Poster Session (North America, Europe, China Annual Meetings)
- Discount registration (North America and Europe Annual Meetings)
- Group Discounts for DIA Student Chapter members
- Student Membership
- Student Engagement at DIA Annual Meeting
- Student Chapters
DIA 2014 50th Annual Meeting Student Session Reports
Monday, June 16
View Session 107. Pioneering Regenerative Medicine: Trends in Regulations for New Therapy
View Session 129. Regulatory Submissions: Better, Faster, and Cheaper
Tuesday, June 17
View Session 211. Clinical Outcomes Assessment & Patient Engagement Symposium
View Session 215. The Regulatory Intelligence Function: Evolution over the Past Decade in an Expanded Global Marketplace
View Session 221. Benefit-Risk Throughout the Life Cycle: How Should Benefit-Risk Be Evaluated and Communicated from Development through Marketing as New Information Emerges?
View Session 246. EMA-FDA Collaboration in Pharmacovigilance: Common Objectives & Common Challenges
View Session 262. First-in-Human Studies: How Much Complexity Is Too Much?
Wednesday, June 18
View Session 319. Signal Detection: Challenges & Strategic Aspects
EMA Press Release: Pharmacovigilance Risk Assessment Committee: One year of Public Health Promotion and Protection
Medical Students Remain Unfazed by Professors Industry Relationships
Through DIA’s worldwide conferences and programs, patient representatives have opportunities to develop, strengthen, and support collaborations with policymakers, health professionals, industry representatives, and academia while promoting dialogue and sharing best practices.